URIN DS (HYOSCYAMINE SULFATE 0.12 MG / METHENAMINE 81.6 MG / METHYLENE BLUE 10.8 MG / PHENYL SALICYLATE 36.2 MG / SODIUM PHOSPHATE, MONOBASIC 40.8 MG) ORAL TABLET

Side Effects & Adverse Event Reports


View Chart Data

82

Adverse Events

128

Side Effects

2014

Data Starting In

This report has a limited number of adverse event reports which may not fully reflect the safety profile of this product. It's important to understand that:

  • Only manufacturers are required to report adverse events — for everyone else, reporting is voluntary.
  • It's estimated that only about 10% of adverse events are ever reported.
  • Some people may not realize their experience qualifies as an adverse event.
  • Others may assume someone else has already reported the issue.
  • A lack of awareness about how and where to report can also reduce submissions.
Your report can help close this gap. Whether your experience was mild or serious, sharing it contributes to a fuller understanding of product safety and can help others make better health decisions.

SymPedia Mobile App

Get our Mobile App for easy access to the latest reports on URIN DS (HYOSCYAMINE SULFATE 0.12 MG / METHENAMINE 81.6 MG / METHYLENE BLUE 10.8 MG / PHENYL SALICYLATE 36.2 MG / SODIUM PHOSPHATE, MONOBASIC 40.8 MG) ORAL TABLET.

Understanding the potential Side Effects and Adverse Events of URIN DS (HYOSCYAMINE SULFATE 0.12 MG / METHENAMINE 81.6 MG / METHYLENE BLUE 10.8 MG / PHENYL SALICYLATE 36.2 MG / SODIUM PHOSPHATE, MONOBASIC 40.8 MG) ORAL TABLET is essential for making informed health decisions. Our application provides in-depth reports based on real-world data, helping you explore how URIN DS (HYOSCYAMINE SULFATE 0.12 MG / METHENAMINE 81.6 MG / METHYLENE BLUE 10.8 MG / PHENYL SALICYLATE 36.2 MG / SODIUM PHOSPHATE, MONOBASIC 40.8 MG) ORAL TABLET may affect your health.

View reports containing much more information including:

  • Age group - See how different age ranges experience side effects and adverse reactions.
  • Year - Track trends over time to understand changes in reported issues.
  • Biological sex - Compare how reports vary between men and women.
  • Weight - Examine the impact of body weight on side effects and adverse events.
Download Now

Frequently Asked Questions

Some questions about URIN DS (HYOSCYAMINE SULFATE 0.12 MG / METHENAMINE 81.6 MG / METHYLENE BLUE 10.8 MG / PHENYL SALICYLATE 36.2 MG / SODIUM PHOSPHATE, MONOBASIC 40.8 MG) ORAL TABLET are asked frequently. We've answered the most frequent of those questions below

  • How many adverse events have been reported for URIN DS (HYOSCYAMINE SULFATE 0.12 MG / METHENAMINE 81.6 MG / METHYLENE BLUE 10.8 MG / PHENYL SALICYLATE 36.2 MG / SODIUM PHOSPHATE, MONOBASIC 40.8 MG) ORAL TABLET?

    URIN DS (HYOSCYAMINE SULFATE 0.12 MG / METHENAMINE 81.6 MG / METHYLENE BLUE 10.8 MG / PHENYL SALICYLATE 36.2 MG / SODIUM PHOSPHATE, MONOBASIC 40.8 MG) ORAL TABLET has 82 adverse event reports in this SymPedia dataset.

  • How many side effects have been reported for URIN DS (HYOSCYAMINE SULFATE 0.12 MG / METHENAMINE 81.6 MG / METHYLENE BLUE 10.8 MG / PHENYL SALICYLATE 36.2 MG / SODIUM PHOSPHATE, MONOBASIC 40.8 MG) ORAL TABLET?

    URIN DS (HYOSCYAMINE SULFATE 0.12 MG / METHENAMINE 81.6 MG / METHYLENE BLUE 10.8 MG / PHENYL SALICYLATE 36.2 MG / SODIUM PHOSPHATE, MONOBASIC 40.8 MG) ORAL TABLET has 128 side effect reports in this SymPedia dataset.

  • What year does the URIN DS (HYOSCYAMINE SULFATE 0.12 MG / METHENAMINE 81.6 MG / METHYLENE BLUE 10.8 MG / PHENYL SALICYLATE 36.2 MG / SODIUM PHOSPHATE, MONOBASIC 40.8 MG) ORAL TABLET reporting data start?

    The reporting data on this page starts in 2014.

  • What years are included in the yearly chart for URIN DS (HYOSCYAMINE SULFATE 0.12 MG / METHENAMINE 81.6 MG / METHYLENE BLUE 10.8 MG / PHENYL SALICYLATE 36.2 MG / SODIUM PHOSPHATE, MONOBASIC 40.8 MG) ORAL TABLET?

    The yearly chart on this page includes data from 2014 to 2025.

  • Is adverse event reporting mandatory?

    Only manufacturers are required to report adverse events. For other reporters, submission is generally voluntary, which can lead to underreporting.